Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Adm Policy Ment Health ; 50(5): 725-733, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37261566

RESUMO

To estimate the cost of implementing a clinical program designed to support safer use of antipsychotics in children and adolescents (youth) age 3-17 years at the time of initiating an antipsychotic medication. We calculate the costs of implementing a psychiatric consultation and navigation program for youth prescribed antipsychotic medications across 4 health systems, which included an electronic health record (EHR) decision support tool, consultation with a child and adolescent psychiatrist, and up to 6 months of behavioral health care navigation, as well as telemental health for patients (n = 348). Cost data were collected for both start-up and ongoing intervention phases and are estimated over a 1-year period. Data sources included study records and time-in-motion reports, analyzed from a health system perspective. Costs included both labor and nonlabor costs (2019 US dollars). The average total start-up and ongoing costs per health system were $34,007 and $185,174, respectively. The average total cost per patient was $2,128. The highest average ongoing labor cost components were telemental health ($901 per patient), followed by child and adolescent psychiatrist consultation ($659), and the lowest cost component was primary care/behavioral health provider time to review/respond to the EHR decision support tool and case consultation ($24). For health systems considering programs to promote safer and targeted use of antipsychotics among youth, this study provides estimates of the full start-up and ongoing costs of an EHR decision support tool, psychiatric consultation service, and psychotherapeutic services for patients and families.Trial registration: Clinicaltrials.gov, NCT03448575.


Assuntos
Antipsicóticos , Criança , Humanos , Adolescente , Pré-Escolar , Antipsicóticos/efeitos adversos , Encaminhamento e Consulta , Medicina Baseada em Evidências
2.
Health Aff (Millwood) ; 32(5): 998-1006, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23650332

RESUMO

To help contain health care spending and improve the quality of care, practitioners and policy makers are trying to move away from fee-for-service toward value-based payment, which links providers' reimbursement to the value, rather than the volume, of services delivered. With funding from the Robert Wood Johnson Foundation, eight grantees across the country are designing and implementing value-based payment reform projects. For example, in Salem, Oregon, the Physicians Choice Foundation is testing "Program Oriented Payments," which include incentives for providers who follow a condition-specific program of care designed to meet goals set jointly by patient and provider. In this article we describe the funding rationale and the specific objectives, strategies, progress, and early stages of implementation of the eight projects. We also share some early lessons and identify prerequisites for success, such as ensuring that providers have broad and timely access to data so they can meet patients' needs in cost-effective ways.


Assuntos
Aquisição Baseada em Valor , Controle de Custos/métodos , Atenção à Saúde/economia , Atenção à Saúde/organização & administração , Organização do Financiamento , Fundações , Reforma dos Serviços de Saúde/organização & administração , Humanos , Projetos Piloto , Melhoria de Qualidade/organização & administração , Mecanismo de Reembolso/organização & administração , Estados Unidos , Aquisição Baseada em Valor/organização & administração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA